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The recent isolation ofcDNA and genomic clones corresponding to the a and
/3 chains of the T cell antigen receptor (TCR) of both mice and humans has
permitted a number of studies regarding evolution of these genes (1-3). Both
the a and ,Q chain genes show organizational and structural homology to immu-
noglobulins (1-4) in that there are variable (V), diversity (D), joining (J), and
constant (C) region gene segments that are separated in germline DNA. These
segments undergo rearrangement during T cell ontogeny to assemble a func-
tional gene capable of encoding the corresponding protein product (5, 6). The
(3 gene complex contains two highly similar C region genes (CT0, and CTN2), each
of which is associated at its 5' end with a cluster of JTa and DTQ gene segments
(for CTR2, there is only one DT02 gene segment [7-10]). Both the CTQ genes are
divided into four exons separated by corresponding introns. The two CTR
constant genes are present and highly conserved in all inbred mice (11), with the
marked exception of NZW, which has lost CT0,, DT,Q2, and JT02 regions (12),
and SJL, which displays a restriction fragment polymorphism for the CTRL gene
only (13). A similar locus organization has been found in humans, indicating that
the presumed duplication ofa primordial CTO gene giving rise to CA and CT02
occurred before the divergence of mice and humans. Surprisingly, comparison
of CA and CT02 sequences in either mouse or humans revealed only minimal
divergence in the exon 1 region, suggesting the occurrence of some form of
gene correction. Because the apparent correction of CTR sequences, possibly by
a mechanism such as gene conversion, is of such potential biological import, and
because this putative correction has occurred in such a pauci-gene family in
contrast to its more usual association with larger multigene families, we have
further examined evolutionary mechanisms operating at this locus by cloning
and sequencing the CTO genes from Mus pahari (Pa), believed to be the most
ancient mouse species existing today. Our results indicate that a correctional
event independent of that seen in inbred mice has occurred in this natural
population to similarly maintain exon 1 homology.
Materials and Methods
Genomic Clones and Sequence Determination.
￿
A Pa recombinantlibrarywas constructed
by ligating fragments of ^-20 kb length derived from partial Mbo I digestion of liver DNA
from two individuals into XJ, vector (14). 2 x 106 phage were screened by filter hybridi-
zation under high-stringency conditions (0.1 x SSC, 0.1% SDS, 65°C) with 86T5, a
cDNA probe containing constant region sequences of the T cell receptor 0 chain (2).
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Sequencing was performed by the chain termination procedure of Sanger (15) using M13
phage vectors (16).
Results and Discussion
We have chosen to approach the question of mutational mechanisms operating
on CTO genes by an examination of this locus in our wild mouse colony that
contains representatives ofall four subgenera ofMus. Two CTO genes are readily
detectable in all wild species from our colony, but the pattern of hybridizable
fragments is very different from that observed in M. musculus domesticus (17).
We have begun analysis of these restriction polymorphisms by characterizing the
CT# genes from Pa, a member of the subgenus coelomys, believed to be the most
evolutionary distant species from inbred laboratory mice. Two hybridizing
fragments are detectable by Southern blot analysis (not shown) in Pa genomic
DNA, suggesting the presence of two CT,O genes, although both fragments are
polymorphic in comparison to those of inbred mice (17) . To further characterize
these genes, a genomic library was screened and a phage clone isolated that
contained two hybridizing fragments separated by ^-6 kb. Because both hybrid-
izing fragments are present in a single phage, the insert presumably contained
CA and CT#2 from a single haplotype. This assessment was subsequently
confirmed by sequence comparison with BIO.A CA and CT02 genes. Sequences
obtained for the two genes, designated PaCT01 and PaCT#2, are presented in
Fig. 1. As has been found for the inbred mouse and for humans, both CTO genes
have the same transcriptional orientation and consist of four exons separated by
introns of different sizes. In the PaCTf1 gene, the intron sizes are 491, 96, and
312 bp, and in PaCTf2, they are 487, 144, and 285 bp. In comparison, introns
from the CTa2 gene of the inbred B10.A mouse are 506, 145, and 383 nucleo-
tides, respectively. Complete nucleotide sequences are not available for the CA
introns. Consensus donor and acceptor RNA splice signals are located adjacent
to each exon, and a termination codon is found at the 3' end of exon 4 that is
separated by 199 and 153 bp, respectively, from the CT01 and CT132 polyadenyl-
ation signals. The three potential glycosylation sites present in B10.A genes are
also conserved in Pa. Thus, the two PaCT,B genes have all characteristics of
functional CTO genes.
A comparison of the PaCT01 and PaCT#2 sequences reveals striking variation
in the degree of homology in different regions of the two genes. As might be
expected, the exons are in general quite conserved and the introns are highly
divergent. However, only four mutations are observed in the exon 1 sequence,
of which three are silent. The transmembrane region is more divergent, with 18
mutations and six amino acid changes between the two genes. The smaller exons
2 and 4 are also slightly more divergent than their B10.A counterparts. A total
of 30 mutations are observed between exons of PaCT01 and PaCT#2, encoding
10 amino acid substitutions, in comparison to 23 mutations and 4 amino acid
substitutions in BlO.A . A predominance of silent substitutions is seen throughout
these genes, indicating selection against replacement changes.
The observed four substitutions in the exon 1 region between PaCTf1 and
PaCT#2 is much less than would be expected considering the divergence in other
regions of the molecule and the presumed separation time between Pa and M.FIGURE 1 .
￿
Genomic clone and sequence determination of Pa CTß genes. Restriction maps
and sequences were generated using the followingenzymes : B, Bam HI ; E, Eco RI ; K, Kpn;
H, Hae III ; P, Pst I ; R, Rsa I; S, Sau 3A ; Sc, Sac 1; St, Stu I ; X, Xba I . Sequencing was
performedby the chain-termination procedure ofSanger et al . (15), as indicated by thearrows.
Exons and introns are depicted as solid and open boxes, respectively, and hatched areas
correspond to 3' untranslated regions. Nucleotide and predicted amino acid sequences were
aligned to maximize homology, with insertion of gaps where necessary . Dashed lines in the
PaCT#2 sequence indicate homology to PaCTß1 . Splice signals and polyadenylation sites are
marked with asterisks.
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TABLE I
Exon 1 Sequence Differences between M. pahari and M. m. domesticus
Substitutions shared between the two CT# genes in a species-specific manner are underlined.
TABLE II
Percent Sequence Divergence between M. pahari, B10.A, andHuman C,fl Genes
* Intron comparisons involving the BIO.ACTt2, gene are based on limited sequences available in the literature (2)
and constitute 61 by of the 5' flanking region and a total of 336 by in introns. Regions for comparison were
defined by exon/intron boundaries, except for the first 105 by of intron 1, which have been compared
independently. Coding regions of exons 2 and 4 were not included due to their small size.
m. domesticus. The similar lack of exon 1 mutations between CT(JI and CT#2 genes
in both BIO.A and humans has led to the speculation that some form of gene
correction (i.e., double crossover or gene conversion) has operated to prevent
divergence of this segment. When exon I sequences of both CT0l and CT02 are
compared between Pa and M. m. domesticus, 16 positions are noted at which
sequence differences occur. At 11 of these (Table I), the substitutions are shared
between CT0 l and CT#2 in a species-specific manner. There appears to be some
tendency toward clustering of these substitutions, although the data is toolimited
to permit a clear determination. Several of the interchanges result in nonconser-
vative replacements, such as glutamic acid for lysine (codon 17), asparagine for
tyrosine (codon 67) and glutamic acid for serine (codon 99). For each of the
other five positions, three sequences out of four are identical, with no pattern as
to which sequence contains the mutation. It therefore appears that, in each
species, the CA and CT,Q2 sequences have been independently corrected in a cis
manner. This correction appears to be localized specifically to exon 1, as
sequences 5' of the exon and in the intron immediately 3' are highly divergent
(Table II). In contrast, the 5' region of the intron in the human CTO genes also
appears to have been corrected (6). Where comparisons are possible, other
regions of the PaCT01 and CT02 genes are as divergent from each other as the
B10.A genes. Interestingly, the human genes are considerably less divergent
from each other in all segments from the 5' flanking region through exon 3 (6).
The extreme sequence divergence between PaCT#1 and CT#2 in flanking and
intron regions, compared with the high homology between PaCT#1 -B10 .ACT#1
PaCT01
PaCTtts
B.ACTth
B.ACTR2
hUCT0 ,pI
hUCT02
PaCTRI
B.ACTS,
PaCT6,
hUCTt1,
PaCTt32
B.ACT02
PaCT#2
huCT#2
5' flanking region 59.2 31.0 19.1 14.7 46.6 11 .5 46.6
Exon 1 1.1 0.2 1.3 3.5 19.4 3 .7 19.4
Intron 1* 58.2 34.3 9.3 46.0 7 .7 44.4
5' Region 62.8 1.1 37.5
Remainder 56.9 42.6 48.5
Intron 2 57.7 25.0 28.1 10.3 39.7 10.3 44.6
Exon 3 16.7 14.9 6.5 4.6 11 .2 7.4 14.9
Intron 3 55.5 34.6 63.6 8.4 47.6 5.6 47.7
3' Noncoding region 61 .7 47.5 69.7 6.2 36.4 3 .7 44.7
Codon number
17 21 22 67 77 79 96 99 109
PaCTR, GAA GCT GAC AAC GTT GCG TAT GAA ACC
PaCT,82 GAA GCT GAC AAC GTT GCG TAT GAA ACC
B10.ACTR, AAA GCA AAC TAT GTC GCT CAT TCA CCC
B10.ACTR2 AAA GCA AAC TAT GTC GCT CAT TCA CCCJOUVIN-MARCHE ET AL.
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and PaCT#2-BIO.ACT02 (Table 11), clearly indicates that neither of these species
has deleted either CT01 or CT02 and subsequently duplicated the remaining gene.
Our results suggest that gene correction is a dynamic process occurring during
the modern evolution of a natural population, and that such correction may not
be a rare occurrence even within pauci-gene families consisting of as few as two
genes. Thus, the observed independent gene correction in these two species
appears to reflect a strong selective pressure to maintain homogeneous CT01 and
CT02 exon 1 sequences that presumably are important in some aspect of func-
tional recognition . The above results, in conjunction with similar observations in
other mammalian gene families such as immunoglobulins (18) and major histo-
compatibility antigens (19, 20), provide an increasing body of evidence implicat-
ing corrective processes such as gene conversion as being of fundamental impor-
tance in the evolution of gene families in higher vertebrates.
Summary
Mutational mechanisms operating at the T cell receptor 0 chain locus have
been examined by comparison of the CA and CT02 gene sequences from Mus
pahari, believed to be the oldest living species in the genus Mus, with those of
inbred mice. Results indicate that a gene correction event independent of that
suggested to have occurred in inbred mice has homogenized the M. pahari CTN
exon 1 sequences, minimizing diversity in this region of the molecule. These
observations suggest that correction events such as gene conversion may occur
frequently, even in pauci-gene families with as few as two members, and therefore
play a significant role in gene diversification or homogenization of small as well
as large gene families.
We thank Dr. M. Davis for the 86T5 cDNA clone, and Ms. M. Millison for preparation
of the manuscript.
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